Old Web
English
Sign In
Acemap
>
authorDetail
>
Florence Porte Thomé
Florence Porte Thomé
Duchenne muscular dystrophy
Diabetes mellitus
Rimeporide
Medicine
Heart failure
3
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Protective effects of rimeporide on left ventricular function in golden retriever muscular dystrophy dogs.
2020
International Journal of Cardiology
Bijan Ghaleh
Inès Barthélémy
Jérôme Wojcik
Lucien Sambin
Alain Bizé
Luc Hittinger
Thien-Duc Tran
Florence Porte Thomé
Stéphane Blot
Jin Bo Su
Show All
Source
Cite
Save
Citations (4)
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy.
2020
Pharmacological Research
Stefano C. Previtali
Teresa Gidaro
Jordi Díaz-Manera
A. Zambon
Stephanie Carnesecchi
Pascale Roux-Lombard
Pietro Spitali
Mirko Signorelli
Cristina Al-Khalili Szigyarto
Camilla Johansson
Julian Gray
Delphine Labolle
Florence Porte Thomé
Jacqueline Pitchforth
J. Domingos
Francesco Muntoni
Show All
Source
Cite
Save
Citations (5)
Rimeporide in patients with Duchenne Muscular Dystrophy
2017
European Journal of Paediatric Neurology
Florence Porte Thomé
Hanane Gheit
Dominic J. Wells
Inès Barthélémy
Jinbo Su
Stéphane Blot
Bijan Ghaleh
Francesco Muntoni
Show All
Source
Cite
Save
Citations (0)
1